Pharmaceutical Products

Health written question – answered on 16th January 2007.

Alert me about debates like this

Photo of Sandra Gidley Sandra Gidley Shadow Minister, Health

To ask the Secretary of State for Health what assessment she has made of the likely financial effect upon the NHS of changes to the distribution of pharmaceutical products by (a) AstraZeneca and (b) Lilly.

Photo of Caroline Flint Caroline Flint Minister of State (Department of Health) (Public Health)

Officials understand that neither company has finalised any changes to their distribution arrangements.

The Department will monitor any new arrangements. If the changes result in shortages, disruptions to supply, any additional costs to the national health service, or has a detrimental affect on funding pharmacy contractors then the Department will seek to ensure the corrective action is taken.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.